Following is an email sent today to NP:

Nader:

In today's call, please explain the following:

1. The reason the non-binding agreement, you told shareholders would be concluded long ago, was put on hold;

2. The status of other licensing/partnership agreements;

3. What happened to the non-dilutive financing you announced would be attained by the end of 2019;

4. The status of the final BLA submission;

5. The status of efforts to sell Dr. Pestell's prostate cancer test; and

6. The reason you have never purchased any stock.

In today's call, please do NOT speak about the following:

A. The share price being too low;

B. Our "loyal shareholders";

C. Leronlimab being the next Humira; and

D. The company being "very close" to making a deal, obtaining non-dilutive financing, or doing anything else, for that matter, unless concrete details and actual dates are announced.

Thank you.